Investors focused on the Medical space have likely heard of Sunesis Pharmaceuticals (SNSS), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer ...
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get ...
FORT LEONARD WOOD, Mo. — Social networking sites, or SNSs for short, are great ways to connect with people, share information and market products and services. However, they can also provide ...
As of late, it has definitely been a great time to be an investor in Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) . The stock has moved higher by 30% in the past month, while it is also above its 20 ...
SOUTH SAN FRANCISCO, Calif., July 13 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS - News), a biopharmaceutical company focused on the ...
Sunesis Pharmaceuticals (NASDAQ:SNSS) is up more than 20% in trading today after analysts at Oppenheimer upgraded the stock to “outperform.” Those analysts set a price target for SNSS stock of $12, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results